Live feed
·
INSIDERFiling
CRISPR Therapeutics AG logo

Chief Executive Officer Kulkarni Samarth sold $499,443 worth of shares (10,349 units at $48.26) and converted options into 20,625 shares, increasing direct ownership by 4% to 245,834 units (SEC Form 4)